Actinium Pharmaceuticals
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $810 | $0 |
Gross Profit | -204 | -205 | 405 | -202 |
EBITDA | -7,503 | -16,638 | -7,301 | -12,399 |
EBIT | -16,843 | -7,505 | -12,601 | |
Net Income | -6,878 | -15,938 | -6,652 | -11,568 |
Net Change In Cash | 0 | 0 | 810 | 0 |
Free Cash Flow | -5,392 | -7,574 | -5,751 | -11,975 |
Cash | 59,928 | 65,325 | 72,904 | 78,660 |
Basic Shares | 31,195 | 31,196 | 31,196 | 31,071 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $81 | $1,030 | $1,144 |
Gross Profit | -811 | 81 | 1,030 | 1,144 |
EBITDA | -37,432 | -51,130 | -33,405 | -24,440 |
EBIT | -38,243 | -51,920 | -34,104 | -24,964 |
Net Income | -38,243 | -48,818 | -33,017 | -24,774 |
Net Change In Cash | 0 | 81 | 1,030 | 1,144 |
Cost of Revenue | 14,222 | |||
Free Cash Flow | -33,083 | -47,488 | 8,278 | -20,999 |
Cash | 72,904 | 76,677 | 108,910 | 77,829 |
Basic Shares | 30,070 | 26,604 | 24,142 | 20,568 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.22 |
2025-03-31 | -$0.51 |
2024-12-31 | -$0.21 |
